respiratori
syncyti
viru
noninfluenza
respiratori
viru
outbreak
elderli
longterm
care
facil
multiplex
respiratori
viral
panel
among
older
adult
morbid
mortal
respiratori
syncyti
viru
infect
similar
influenza
sever
respiratori
virus
human
metapneumoviru
parainfluenza
viru
rhinoviru
coronaviru
adenoviru
may
caus
outbreak
among
resid
longterm
care
facil
support
care
mainstay
medic
therapi
effect
antivir
vaccin
yet
exist
noninfluenza
respiratori
virus
rapid
diagnost
molecular
test
augment
epidemiolog
understand
noninfluenza
respiratori
viral
outbreak
infect
prevent
control
measur
contagi
individu
includ
hand
hygien
cough
etiquett
use
mask
gown
glove
health
care
worker
infect
di
clin
n
http
dx
respiratori
tract
infect
common
caus
morbid
mortal
older
adult
influenza
pneumonia
account
death
among
adult
year
older
unit
state
older
adult
especi
older
year
age
experi
highest
rate
influenzaassoci
mortal
rate
among
age
group
avail
rapid
diagnost
test
antivir
medic
notabl
season
influenza
vaccin
mitig
influenza
devast
effect
respiratori
virus
influenza
also
caus
signific
morbid
mortal
among
older
adult
particularli
resid
longterm
care
facil
ltcf
virus
includ
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
parainfluenza
viru
rhinoviru
coronaviru
adenoviru
articl
review
virus
influenza
common
caus
respiratori
infect
older
adult
discuss
relev
diagnost
test
transmiss
infect
prevent
control
measur
unit
state
nation
respiratori
enter
viru
surveil
system
voluntari
laboratorybas
system
affili
center
diseas
control
prevent
cdc
monitor
tempor
geograph
pattern
associ
detect
rsv
hmpv
parainfluenza
virus
respiratori
adenovirus
data
nation
respiratori
enter
viru
surveil
system
inform
report
cdc
regard
ongo
trend
detect
respiratori
virus
although
comprehens
nation
respiratori
enter
viru
surveil
system
data
includ
patient
demograph
therefor
specif
provid
inform
epidemiolog
respiratori
virus
older
adult
ltcf
addit
rule
influenza
effect
antivir
therapi
molecular
diagnost
test
yet
wide
use
evalu
older
adult
ltcf
resid
respiratori
infect
accordingli
understand
epidemiolog
noninfluenza
respiratori
infect
among
older
adult
inform
research
studi
descript
outbreak
ltcf
tabl
first
isol
chimpanze
rsv
nonseg
singlestrand
negativesens
rna
viru
within
paramyxovirida
famili
tabl
recogn
effect
children
rsv
also
caus
sever
infect
among
older
adult
similar
influenza
gener
circul
fall
spring
peak
januari
protein
surfac
viru
dub
f
protein
caus
cell
membran
nearbi
cell
fuse
form
syncytia
viru
name
among
older
adult
rsv
caus
morbid
mortal
rival
influenza
falsey
colleagu
describ
rsv
infect
among
older
adult
consecut
winter
among
older
adult
hospit
respiratori
viral
infect
n
age
ae
year
author
detect
roughli
similar
proport
rsv
influenza
case
respect
furthermor
also
found
peopl
rsv
influenza
similar
rate
intens
care
stay
vs
mortal
vs
respect
among
communitydwel
popul
preval
vaccin
influenza
streptococcu
pneumonia
greater
incid
rsv
similar
nonpandem
influenza
data
given
unit
kingdom
seventeen
resid
age
develop
fever
anorexia
nonproduct
cough
pair
sera
case
show
increas
rsv
complement
fixat
titer
one
resid
die
sever
chest
infect
sorvillo
et
al
rate
rsv
infect
death
parallel
influenza
among
ltcf
resid
well
ltcf
california
report
outbreak
rsv
attack
rate
case
fatal
rate
among
nurs
home
tennesse
consecut
year
rsv
contribut
averag
hospit
antibiot
cours
death
per
person
year
comparison
influenza
caus
averag
hospit
antibiot
cours
death
per
person
year
activ
surveil
symptomat
asymptomat
respiratori
viral
infect
detect
rsv
outbreak
ltcf
north
carolina
among
resid
develop
respiratori
tract
infect
rsv
infect
confirm
use
revers
transcriptas
polymeras
chain
reaction
rtpcr
one
resid
requir
hospit
subsequ
die
studi
particular
notabl
use
rtpcr
support
time
accur
recognit
rsv
outbreak
although
activ
surveil
rsv
may
use
earli
diagnosi
therefor
outbreak
prevent
expens
resourc
use
involv
may
render
impract
ltcf
influenza
spectrum
clinic
diseas
caus
rsv
infect
divers
heterogen
tabl
younger
adult
may
reinfect
everi
year
may
manifest
symptom
mild
cold
sinu
infect
remain
asymptomat
older
adult
rsv
may
caus
selflimit
upper
respiratori
tract
infect
pharyng
rhinosinus
pneumonia
respiratori
failur
death
unfortun
clinic
manifest
permit
identif
specif
viral
pathogen
includ
rsv
prospect
studi
walsh
colleagu
assess
clinic
characterist
older
adult
live
commun
retir
home
admit
hospit
acut
respiratori
ill
use
cultur
rtpcr
serolog
analysi
combin
test
identifi
patient
rsv
infect
influenza
viru
report
rsv
compar
influenza
commonli
associ
nasal
congest
vs
p
lower
temperatur
admiss
c
vs
c
p
wheez
histori
vs
p
physic
examin
vs
p
although
factor
independ
predictor
rsv
infect
person
none
suffici
sensit
specif
accur
discrimin
ill
caus
rsv
versu
influenza
among
rsvinfect
adult
diseas
sever
correl
increas
level
viral
shed
proinflammatori
cytokin
associ
physic
function
declin
chronic
diseas
studi
rsvinfect
adult
show
hospit
patient
compar
outpati
greater
nasal
level
shed
rsv
longer
ae
day
vs
ae
day
respect
furthermor
hospit
adult
requir
mechan
ventil
rsvrelat
respiratori
failur
manifest
higher
peak
rsv
viral
load
compar
log
ae
pfusml
vs
log
ae
pfusml
respect
p
similarli
among
adult
hospit
pcrconfirm
rsv
infect
n
age
ae
year
increas
concentr
viral
rna
associ
respiratori
insuffici
risk
complic
adjust
odd
ratio
per
increas
log
copiesml
ci
p
togeth
studi
indic
high
rsv
viral
load
correl
diseas
sever
agerel
immun
senesc
may
increas
older
adult
risk
develop
rsv
infect
subsequ
hospit
admiss
older
adult
lower
serum
rsv
neutral
antibodi
like
becom
infect
rsv
requir
hospit
admiss
prospect
studi
adult
enrol
day
care
program
compar
serum
antirsv
antibodi
titer
infect
subgroup
n
control
match
age
exposur
recent
respiratori
ill
mean
titer
neutral
antibodi
rsv
significantli
lower
rsvinfect
patient
compar
control
group
ae
vs
ae
p
respect
group
b
viru
ae
vs
ae
p
respect
similar
studi
evalu
antibodi
titer
among
prospect
cohort
adult
rsv
infect
n
hospit
rsv
multivari
analysi
show
increas
risk
hospit
odd
ratio
ci
p
among
adult
low
serum
antirsv
antibodi
level
defin
less
dilut
infect
rsvspecif
antibodi
provid
protect
reinfect
level
usual
decreas
within
month
studi
evalu
adult
report
increas
rsv
antibodi
titer
rsv
infect
within
year
howev
rsv
antibodi
titer
decreas
least
adult
studi
immun
complet
preced
infect
reinfect
occur
throughout
life
hmpv
first
describ
common
caus
respiratori
infect
among
age
group
circul
winter
spring
temper
climat
like
rsv
hmpv
member
paramyxovirida
famili
divid
genotyp
b
includ
subtyp
given
varieti
genotyp
season
shift
predomin
genotyp
occur
year
similar
influenza
viru
epidemiolog
prospect
studi
tennesse
found
similar
rate
infect
hmpv
influenza
among
hospit
adult
consecut
winter
widmer
colleagu
enrol
individu
year
older
live
commun
hospit
respiratori
symptom
nonloc
fever
rtpcr
test
nasal
swab
detect
hmpv
influenza
viru
hospit
individu
patient
hmpv
compar
laboratoryconfirm
influenza
older
median
age
vs
cardiovascular
diseas
vs
like
receiv
influenza
vaccin
vs
notabl
also
less
like
report
fever
vs
sever
report
describ
notabl
morbid
mortal
associ
hmpv
outbreak
ltcf
resid
resid
ltcf
quebec
citi
canada
present
respiratori
constitut
symptom
sampl
obtain
nasopharyng
swab
nasopharyng
aspir
realtim
multiplex
rtpcr
detect
hmpv
resid
fatal
rate
patient
among
confirm
hmpv
case
resid
ltcf
oregon
met
case
definit
sever
respiratori
tract
infect
pneumonia
hospit
die
six
nasopharyng
swab
specimen
collect
afflict
resid
test
posit
hmpv
similarli
winter
skill
nurs
facil
idaho
washington
also
experienc
hmpv
outbreak
among
resid
lower
respiratori
tract
infect
pneumonia
die
hmpv
outbreak
describ
outbreak
investig
queri
staff
care
resid
found
also
experienc
symptom
acut
respiratori
ill
clinic
manifest
hmpv
infect
adult
similar
children
nonspecif
upper
respiratori
symptom
includ
cough
nasal
congest
although
asymptomat
infect
common
sever
prospect
studi
assess
symptom
manifest
older
adult
older
adult
develop
dyspnea
wheez
frequent
younger
adult
although
symptom
specif
hmpv
compar
influenza
howev
fever
report
less
frequent
vs
prospect
studi
adult
hospit
communityacquir
pneumonia
johnston
colleagu
use
rtpcr
nasopharyng
swab
detect
hmpv
case
influenza
season
concomit
blood
sputum
assay
viru
atyp
bacteri
pathogen
neg
specif
risk
factor
hmpv
infect
older
adult
resid
ltcf
yet
known
human
parainfluenza
viru
hpiv
singlestrand
neg
sens
rna
viru
yet
anoth
member
paramyxovirida
famili
first
detect
viru
major
serotyp
parainfluenza
viru
gener
circul
spring
winter
differ
season
peak
depend
serotyp
children
caus
croup
preval
serotyp
associ
bronchiol
pneumonia
two
report
describ
larg
populationbas
studi
detail
morbid
mortal
hpiv
older
adult
communic
diseas
surveil
center
unit
kingdom
receiv
laboratori
report
hpiv
infect
although
posit
hpiv
sampl
came
older
adult
individu
pneumonia
lower
respiratori
tract
infect
populationbas
studi
adult
age
older
netherland
estim
number
death
attribut
hpiv
author
report
lower
rate
mortal
caus
hpiv
compar
influenza
rsv
sever
report
describ
hpiv
outbreak
ltcf
owe
resid
staff
ltcf
ontario
canada
develop
respiratori
tract
infect
pair
sera
ill
resid
show
greater
increas
antibodi
one
resid
hospit
although
none
die
resid
skill
nurs
unit
wisconsin
veteran
home
develop
new
respiratori
symptom
viral
cultur
resid
test
grew
viral
cultur
typic
less
sensit
pcrbase
detect
method
like
underestim
true
preval
three
resid
requir
hospit
die
resid
present
respiratori
symptom
residenti
age
care
facil
australia
nine
nasopharyng
swab
test
posit
pcr
two
resid
hospit
none
die
outbreak
indic
compar
rsv
hmpv
hpiv
outbreak
ltcf
similar
rate
attack
morbid
healthi
immunocompet
adult
hpiv
infect
usual
asymptomat
caus
mild
respiratori
symptom
indistinguish
common
respiratori
virus
prospect
studi
etiolog
communityacquir
pneumonia
among
adult
netherland
identifi
hpiv
case
report
investig
outbreak
lobar
pneumonia
ltcf
massachusett
suggest
possibl
associ
pneumonia
pneumonia
preced
hpiv
infect
day
resid
develop
lobar
pneumonia
serum
avail
studi
use
match
control
serolog
evid
recent
infect
upper
respiratori
infect
symptom
preced
month
compar
control
match
odd
ratio
ci
ultim
resid
pneumonia
die
evid
pneumonia
infect
author
note
resid
document
pneumococc
vaccin
identif
eighth
case
pneumonia
nurs
home
resid
receiv
influenza
pneumococc
vaccin
singlestrand
positivesens
rna
viru
human
rhinoviru
hrv
account
common
cold
year
serotyp
hrv
divid
genotyp
b
c
sever
ill
seem
associ
particular
genotyp
temper
climat
hrv
circul
year
round
like
caus
ill
warmer
month
infect
caus
influenza
rsv
predomin
winter
month
hrv
caus
respiratori
infect
everi
age
group
recurr
infect
occur
throughout
life
epidemiolog
rhinoviru
infect
one
common
noninfluenza
respiratori
virus
older
adult
prospect
studi
netherland
evalu
communitydwel
older
adult
acut
respiratori
symptom
viral
infect
pcr
nasopharyng
swab
serolog
detect
rhinoviru
case
follow
coronaviru
influenza
among
symptomfre
control
rate
respect
similar
prospect
surveil
studi
england
found
similar
result
rhinoviru
identifi
respiratori
infect
adult
age
year
coronaviru
influenza
b
next
common
pathogen
multipl
logist
regress
analysi
show
current
smoke
odd
ratio
ci
chronic
medic
condit
odd
ratio
ci
independ
associ
lower
respiratori
complic
chronic
medic
condit
includ
regular
treatment
heart
diseas
respiratori
ill
anoth
highrisk
condit
design
depart
health
similarli
prospect
studi
itali
assess
peopl
year
age
present
emerg
depart
fever
respiratori
ill
februari
march
molecularbas
method
implic
hrv
caus
outbreak
next
preval
viru
influenza
case
outbreak
summer
two
nurs
home
pennsylvania
report
sever
respiratori
diseas
outbreak
associ
hrv
facil
b
resid
experienc
respiratori
ill
specimen
collect
symptomat
resid
facil
b
test
posit
hrv
sampl
respect
rhinovirusposit
case
resid
clinic
radiograph
evid
pneumonia
facil
total
resid
die
sever
respiratori
ill
concurr
hrv
june
ltcf
california
experienc
similar
outbreak
notabl
resid
die
possibl
owe
secondari
bacteri
infect
respiratori
specimen
collect
cultur
posit
rhinoviru
furthermor
sputum
cultur
grew
nontyp
haemophilu
influenza
high
attack
rate
associ
hrv
may
render
larg
number
resid
vulner
secondari
bacteri
infect
ultim
result
morbid
mortal
viru
regard
caus
common
cold
usual
regard
pathogen
low
virul
hrv
may
caus
asymptomat
infect
among
younger
adult
asymptomat
infect
less
common
older
adult
addit
common
cold
symptom
rhinorrhea
cough
sore
throat
hrv
infect
may
caus
asthma
exacerb
children
younger
adult
discuss
may
caus
predispos
ltcf
resid
bacteri
pneumonia
first
describ
human
coronavirus
hcov
also
caus
common
cold
among
age
group
infect
occur
often
winter
spring
compar
summer
fall
coronavirida
famili
compos
singlestrand
positivesens
rna
virus
also
includ
sever
acut
respiratori
syndrom
coronaviru
middl
east
respiratori
syndrom
coronaviru
beyond
scope
review
strain
seem
frequent
associ
human
respiratori
diseas
hcov
caus
upper
respiratori
infect
elderli
peopl
live
commun
two
prospect
studi
rochest
new
york
england
use
increas
antibodi
titer
acut
convalesc
phase
indic
infect
found
evid
infect
respect
communitydwel
older
adult
acut
respiratori
ill
although
hcov
also
one
common
respiratori
virus
ltcf
knowledg
report
describ
hcov
outbreak
ltcf
birch
colleagu
develop
respiratori
symptom
indic
attack
rate
surprisingli
epidemiolog
investig
determin
ltcf
staff
member
index
case
ltcf
second
report
also
describ
outbreak
summer
ltcf
british
columbia
canada
report
resid
staff
member
develop
respiratori
infect
eight
resid
die
interestingli
outbreak
initi
attribut
sever
acut
respiratori
syndrom
coronaviru
owe
crossreact
antibodi
nucleocapsid
protein
virus
subsequ
rtpcr
confirm
togeth
outbreak
suggest
repres
virul
pathogen
older
adult
ltcf
addit
also
highlight
role
ill
health
care
worker
may
transmit
ill
lctf
resid
similar
hmpv
hpiv
hrv
hcov
infect
often
manifest
common
cold
without
specif
defin
characterist
larg
prospect
cohort
studi
walsh
colleagu
detail
clinic
featur
hcov
infect
adult
rochest
new
york
adult
develop
acut
respiratori
ill
winter
month
underw
surveil
rtpcr
serolog
studi
adult
includ
cohort
healthi
older
adult
n
age
ae
year
highrisk
adult
underli
cardiopulmonari
diseas
n
age
ae
year
healthi
young
adult
n
age
ae
year
hospit
group
n
age
ae
year
studi
period
test
identifi
hcov
infect
cohort
symptomat
evid
viral
coinfect
manifest
hcov
infect
among
prospect
cohort
exclud
hospit
group
congest
constitut
symptom
cough
fever
common
mean
temperatur
rang
c
c
asymptomat
infect
defin
greater
increas
hcovspecif
serum
igg
absenc
respiratori
symptom
common
rang
prospect
cohort
among
hcov
infect
hospit
group
infiltr
chest
radiographi
die
although
capabl
caus
acut
exacerb
chronic
obstruct
pulmonari
diseas
communityacquir
pneumonia
hcov
infect
seem
less
sever
caus
rsv
hmpv
piv
adenoviru
human
adenovirus
hadv
member
famili
adenovirida
first
isol
human
adenoid
tissu
doublestrand
dna
virus
serotyp
identifi
caus
varieti
ill
commonli
respiratori
infect
conjunct
gastroenter
limit
descript
specif
focu
hadv
infect
older
adult
kandel
colleagu
report
outbreak
hadv
type
among
resid
ltcf
boston
massachusett
april
may
acut
respiratori
infect
develop
resid
die
nasopharyng
aspir
specimen
initi
test
neg
use
rapid
antigen
test
pcrbase
test
subsequ
confirm
hadv
type
test
highlight
low
sensit
rapid
test
although
peopl
recov
without
complic
infect
hadv
serotyp
may
caus
sever
pneumonia
signific
morbid
mortal
even
among
immunocompet
young
adult
popul
health
perspect
howev
hadv
perhap
less
import
pathogen
older
adult
compar
influenza
respiratori
virus
describ
wide
rang
diagnost
test
may
identifi
caus
viral
respiratori
infect
serolog
test
compar
acut
convalesc
specimen
collect
week
apart
although
use
epidemiolog
research
serolog
test
practic
clinic
care
rapid
antigen
test
advantag
quick
result
limit
use
owe
poor
sensit
specif
clinic
suspicion
diseas
high
neg
test
confirm
anoth
test
method
viral
cultur
neither
sensit
time
outcom
render
unhelp
clinic
practic
laboratori
may
offer
enzym
immunoassay
test
respiratori
virus
also
lack
sensit
us
food
drug
administr
approv
sever
nucleic
acid
amplif
test
clinic
use
test
influenza
repres
commonli
use
singl
viru
assay
multiplex
panel
use
pcr
test
sever
respiratori
virus
practic
strategi
clinic
manifest
permit
identif
specif
viral
pathogen
number
respiratori
virus
test
sensit
specif
detect
viru
differ
depend
multiplex
pcr
test
use
influenza
lack
effect
antivir
medic
combin
cost
associ
nucleic
acid
amplif
test
make
routin
use
studi
impract
clinic
set
potenti
benefit
routin
use
nucleic
acid
amplif
test
acut
respiratori
infect
howev
may
earli
detect
viral
outbreak
ltcf
activ
surveil
may
confer
benefit
reduc
unnecessari
antibiot
use
infecti
diseas
societi
america
endors
approach
clinic
practic
guidelin
address
fever
infect
ltcf
resid
final
identif
viral
pathogen
among
older
adult
communityacquir
pneumonia
may
support
decis
stop
antibiot
thu
support
antibiot
stewardship
practic
demonstr
influenza
vaccin
safe
least
partial
effect
approach
prevent
ill
caus
respiratori
viral
pathogen
although
detail
discuss
vaccin
beyond
scope
articl
pathogen
discuss
rsv
high
prioriti
vaccin
develop
although
none
yet
avail
clinic
use
meantim
effect
prevent
measur
includ
use
transmissionbas
precaut
includ
hand
hygien
social
distanc
part
broader
infect
prevent
control
activ
preval
sheer
number
respiratori
viral
pathogen
mean
despit
best
effort
adult
viral
infect
year
understand
transmiss
respiratori
virus
inform
foundat
infect
prevent
control
focu
appli
principl
resid
ltcf
transmiss
peopl
may
becom
infect
respiratori
virus
direct
contact
person
person
indirect
contact
via
fomit
droplet
contain
respiratori
secret
direct
physic
contact
infect
person
common
effici
import
form
noninfluenza
respiratori
viru
transmiss
indirect
contact
occur
via
exposur
viabl
viral
particl
fomit
contamin
infect
individu
final
suscept
individu
may
breath
droplet
respiratori
secret
infect
person
sneez
cough
cdc
defin
droplet
respiratori
secret
larger
mm
advis
use
surgic
mask
prevent
exposur
gralton
colleagu
evalu
size
particl
produc
adult
children
symptomat
respiratori
infect
report
breath
cough
particip
produc
airborn
particl
less
mm
diamet
contain
viral
rna
find
investig
support
consider
airborn
precaut
outbreak
sever
respiratori
viral
ill
includ
influenza
howev
associ
clinic
outcom
still
lack
addit
airborn
precaut
possibl
outsid
hospit
set
thu
current
recommend
hand
hygien
remain
import
measur
prevent
infect
health
care
set
acut
care
health
care
worker
ltcf
demonstr
defici
hand
hygien
practic
alcoholbas
hand
rub
improv
adher
schweon
colleagu
describ
comprehens
hand
hygien
program
involv
alcoholbas
hand
rub
use
health
care
worker
resid
ltcf
pennsylvania
lower
respiratori
tract
infect
decreas
among
resid
although
outcom
differenti
viral
bacteri
infect
clearli
support
import
role
basic
hand
hygien
practic
prevent
infect
cdc
last
updat
guidelin
isol
precaut
health
care
set
includ
ltcf
gener
recommend
droplet
precaut
addit
standard
precaut
care
individu
possibl
respiratori
viral
infect
notabl
call
use
person
protect
equip
includ
gown
glove
mask
entri
room
peopl
droplet
precaut
also
introduc
respiratori
hygien
cough
etiquett
ask
symptomat
peopl
cover
mouth
nose
sneez
cough
use
tissu
dispos
notouch
receptacl
perform
hand
hygien
soil
hand
respiratori
secret
wear
surgic
mask
toler
maintain
spatial
separ
least
feet
possibl
although
specif
mention
cdc
guidelin
social
distanc
also
reduc
risk
respiratori
viru
transmiss
social
distanc
includ
avoid
peopl
sick
cancel
group
activ
stay
home
work
ill
approach
readili
implement
longterm
care
commun
set
guidelin
address
infect
control
among
health
care
personnel
recogn
staff
may
transmit
respiratori
viral
infect
other
indic
peopl
acut
viral
respiratori
infect
care
highrisk
individu
particularli
commun
outbreak
influenza
rsv
document
also
acknowledg
restrict
infect
health
care
personnel
patient
care
duti
may
possibl
larg
number
personnel
may
viral
respiratori
ill
winter
prospect
studi
health
care
worker
tertiari
care
children
hospit
detect
respiratori
viru
nasal
swab
collect
asymptomat
individu
influenza
season
novemb
april
perhap
greater
concern
subject
report
work
ill
influenzalik
ill
although
find
may
repres
peopl
work
longterm
care
sever
descript
noninfluenza
viral
outbreak
ltcf
suggest
strong
parallel
accordingli
employ
might
consid
strategi
help
health
care
worker
respiratori
ill
minim
contact
ltcf
resid
part
resid
safeti
possibl
cohort
sick
staff
resid
may
help
augment
infect
control
effort
treatment
unlik
influenza
may
treat
specif
effect
antivir
agent
support
care
remain
mainstay
manag
older
adult
respiratori
ill
caus
virus
discuss
support
care
activ
process
includ
frequent
monitor
patient
clinic
statu
improv
addit
featur
support
care
peopl
respiratori
viral
infect
includ
hydrat
treatment
fever
acetaminophen
albuterol
supplement
oxygen
perhap
nebul
salin
viral
infect
may
preced
occur
concurr
bacteri
pneumonia
concomit
secondari
bacteri
lower
respiratori
infect
suspect
patient
respiratori
viral
infect
empir
antibiot
use
falsey
colleagu
investig
adult
hospit
respiratori
ill
find
viral
infect
evid
bacteri
coinfect
assess
use
procalcitonin
specif
bacteri
test
ideal
among
older
adult
viral
pneumonia
suspect
procalcitonin
result
confirm
absenc
bacteri
infect
help
clinician
stop
antibiot
recent
systemat
review
conclud
use
procalcitonin
guid
initi
durat
antibiot
treatment
patient
acut
respiratori
infect
reduc
antibiot
consumpt
associ
higher
mortal
rate
treatment
failur
procalcitonin
yet
avail
pointofcar
test
therefor
still
releg
primarili
use
research
acut
care
set
even
recent
introduct
procalcitonin
determin
patient
mix
viralbacteri
infect
bacteri
superinfect
viral
respiratori
ill
present
signific
clinic
challeng
adult
typic
clinic
sign
symptom
suggest
pneumonia
eg
temperatur
c
c
cough
dyspnea
tachypnea
hypoxia
abnorm
percuss
alter
breath
sound
auscult
leukocytosi
leukopenia
suffici
accur
predict
whether
communityacquir
pneumonia
owe
viral
andor
bacteri
etiolog
addit
consider
atyp
sign
symptom
infect
common
frail
older
adult
decreas
appetit
lethargi
delirium
ageappropri
definit
fever
add
diagnost
uncertainti
pneumonia
gener
let
along
specif
etiolog
molecular
test
improv
detect
bacteri
viral
pathogen
implic
test
result
clinic
care
yet
clear
gadsbi
colleagu
collect
sputum
endotrach
aspir
adult
hospit
communityacquir
pneumonia
base
multiplex
pcr
detect
virus
patient
virus
codetect
bacteria
result
suggest
potenti
deescal
antibiot
case
author
specif
describ
stop
antibiot
therapi
minimum
criteria
develop
loeb
colleagu
initi
antibiot
resid
ltcf
may
offer
guidanc
help
differenti
viral
bacteri
bronchiti
pneumonia
develop
mainli
base
observ
studi
expert
opinion
intent
recommend
reduc
unnecessari
antibiot
use
among
ltcf
resid
resid
respiratori
infect
loeb
minimum
criteria
initi
antibiot
call
assess
vital
sign
temperatur
heart
rate
respiratori
rate
symptom
cough
sputum
rigor
delirium
medic
histori
chronic
obstruct
pulmonari
diseas
criteria
requir
blood
test
imag
studi
permit
help
inform
clinic
decis
activ
monitor
versu
initi
antibiot
resourcelimit
set
set
robust
resourc
diagnost
test
may
provid
specif
guidanc
major
clinic
knowledg
noninfluenza
respiratori
virus
come
pediatr
studi
demonstr
viral
pathogen
also
import
influenc
health
older
adult
rsv
particular
caus
infect
rival
morbid
mortal
caus
influenza
outbreak
virus
discuss
occur
ltcf
also
grave
consequ
frail
older
adult
especi
among
chronic
cardiopulmonari
diseas
unlik
influenza
effect
vaccin
antivir
medic
yet
avail
even
rsv
accordingli
infect
prevent
control
measur
remain
best
protect
pathogen
hand
hygien
import
set
within
health
care
facil
use
mask
gown
glove
may
reduc
risk
infect
transmiss
among
health
care
worker
patient
resid
recent
advanc
rapid
molecular
diagnost
test
may
permit
greater
recognit
consequ
respiratori
viral
infect
among
older
adult
acut
care
set
earli
recognit
viral
infect
among
hospit
patient
may
promot
judici
use
antibiot
within
ltcf
routin
surveil
use
multiplex
pcr
test
may
rapidli
identifi
viral
outbreak
foster
swift
implement
infect
prevent
control
measur
final
better
assess
overal
influenc
noninfluenza
respiratori
pathogen
may
support
innov
lead
effect
antivir
therapi
vaccin
potenti
improv
health
peopl
age
